This topic contains a solution. Click here to go to the answer

Author Question: Why is it thought that children with a difficult temperament are more likely to end up showing ... (Read 104 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
Why is it thought that children with a difficult temperament are more likely to end up showing life-course-persistent antisocial behavior?
 
  a. They have a certain defective gene.
  b. They have grown up under adverse circumstances.
  c. They evoke maladaptive reactions from their parents.
  d. Their brains are unable to form new neural pathways.

Question 2

Studies of antisocial personality disorder in biological and adoptive families have found that the highest rates of antisocial personality disorder (ASPD) are found in children
 
  a. who are raised in adverse environments.
  b. whose adoptive parent had ASPD.
  c. whose biological parent had ASPD.
  d. who are raised in adverse environments and whose biological parents had ASPD.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mjbamaung

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Answer: c.

Answer to Question 2

Answer: d.




melina_rosy

  • Member
  • Posts: 531
Reply 2 on: Jun 22, 2018
Gracias!


Sarahjh

  • Member
  • Posts: 370
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The average office desk has 400 times more bacteria on it than a toilet.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library